artenimol has been researched along with Lung Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.45) | 29.6817 |
| 2010's | 18 (58.06) | 24.3611 |
| 2020's | 11 (35.48) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Han, N; Li, J; Li, LG; Li, QR; Li, TF; Ma, QL; Peng, XC; Wang, MF; Wang, XY; Xu, HZ; Xu, X; Yang, ZY; Yu, TT | 1 |
| Huang, C; Li, Y; Lu, H; Tang, J; Tang, Y; Wang, Y; Xiao, X; Yang, J; Zhang, Y; Zhong, Z | 1 |
| Chen, X; Han, N; Hu, J; Li, LG; Li, QR; Li, TF; Peng, XC; Wang, MF; Xie, ZX; Xu, HZ; Xu, X; Yang, XX; Yang, ZY; Yu, TT | 1 |
| Lai, XY; Shi, YM; Zhou, MM | 1 |
| Chen, LW; Hu, BQ; Huang, JF; Liu, Y; Niu, K; Wang, NN; Zhou, J | 1 |
| Li, X; Li, Z; Lu, X; Shi, X; Sun, Y; Wang, W | 1 |
| Cai, D; Chen, F; Diao, L; Hu, Y; Jin, H; Shen, A; Tao, J; Wang, S | 1 |
| Kumar, R; Panda, AK; Saneja, A | 1 |
| Bader, S; Jendrossek, V; Pelzer, M; Rudner, J; Wilmers, J | 1 |
| Cai, X; Cao, P; Chaib, I; Miao, J; Molina-Vila, MA; Rosell, R; Sun, R; Wang, S | 1 |
| Jin, Z; Li, Y; Wang, H; Wang, Y; Xiao, X; Yang, J; Yue, F; Zhang, Y; Zhou, Q; Zhou, S | 1 |
| Cao, Y; Jiang, AY; Jiang, XF; Jin, H; Wang, H; Wu, Y | 1 |
| An, Z; Li, P; Liu, J; Qi, M; Qi, Y; Shao, H; Wu, H; Xiao, H; Yan, X; Yang, W; Zhan, Y | 1 |
| Bao, Y; Dai, W; Fan, M; Liu, JH; Liu, X; Shen, C; Wu, J; Yu, BY | 1 |
| Kumar, R; Meena, J; Panda, AK; Saneja, A; Singh, M; Singhvi, P; Thiyagarajan, D | 1 |
| Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM | 1 |
| Chen, SS; Hu, W; Lou, XE; Wang, Z; Zhang, JL; Zhou, HJ | 1 |
| Chang, SJ; Chen, IF; Gao, J; Kuo, SM; Sun, Q; Teong, B | 1 |
| An, FF; Liang, L; Liu, YC; Zhang, WW | 1 |
| Chen, XJ; Guo, ZR; Liu, LK; Shu, YQ; Wu, HF; Yang, D; Zhang, JN | 1 |
| Dai, L; Deng, L; He, J; Lei, J; Li, D; Liu, J; Wang, L | 1 |
| Jiang, LX; Li, W; Wang, JD; Wang, JL; Wang, ST; Xin, YX; Xu, ZH; Zuo, ZJ | 1 |
| Li, J; Liao, K; Wang, Z | 1 |
| Chen, YQ; Gao, J; Geng, GJ; Jiang, J; Li, CL; Li, N; Liu, Y; Luo, XY; Mi, YJ; Yu, XY; Zou, ZZ | 1 |
| Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, H; Zheng, L | 1 |
| Fei, J; Li, J; Shen, R; Wang, Q; Ye, D | 1 |
| An, H; Cai, C; Gao, J; Geng, G; Jiang, J; Li, N; Liu, H; Mi, Y; Shen, D; Wu, X; Yang, S; Yu, X; Zheng, L | 1 |
| Chen, H; Dai, H; Gu, S; Li, X; Zhang, Z | 1 |
| Chen, TS; Lu, YY; Pan, WL; Qu, JL; Sun, L; Wei, XB | 1 |
| Chen, M; Chen, TS; Liu, CY; Lu, YY; Qu, JL | 1 |
| Chu, D; Fu, E; Jin, F; Liu, T; Mu, D; Xie, Y; Zhang, W | 1 |
31 other study(ies) available for artenimol and Lung Neoplasms
| Article | Year |
|---|---|
Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Topics: Apoptosis; Artemisinins; Cell Line, Tumor; Chlorophyllides; Ferroptosis; Humans; Lung Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2022 |
Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer.
Topics: Animals; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glucose; Glycolysis; Lung Neoplasms; Mice; Proto-Oncogene Proteins c-myc; Signal Transduction | 2022 |
Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.
Topics: Animals; Carcinoma, Lewis Lung; DNA Damage; Endoplasmic Reticulum Stress; Ferroptosis; Immunotherapy; Lung Neoplasms; Mice; Tumor Microenvironment | 2023 |
Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Ferroptosis; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species | 2023 |
B7-H3 but not PD-L1 is involved in the antitumor effects of Dihydroartemisinin in non-small cell lung cancer.
Topics: Animals; Artemisinins; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms | 2023 |
Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.
Topics: Animals; Artemisinins; Cell Proliferation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplastic Stem Cells; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2021 |
An Annexin V-FITC-Propidium Iodide-Based Method for Detecting Apoptosis in a Non-Small Cell Lung Cancer Cell Line.
Topics: A549 Cells; Annexin A5; Apoptosis; Artemisinins; Carcinoma, Non-Small-Cell Lung; Fluorescein-5-isothiocyanate; Humans; Lung Neoplasms; Propidium | 2021 |
Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation.
Topics: Antioxidants; Artemisinins; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Radiation, Ionizing; Reactive Oxygen Species | 2021 |
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer.
Topics: Acrylamides; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Heme; Heme Oxygenase-1; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2021 |
Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling.
Topics: Animals; Apoptosis; Artemisinins; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Drug Evaluation, Preclinical; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Network Pharmacology; Protein Interaction Maps; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway.
Topics: Apoptosis; Artemisinins; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin B1; Down-Regulation; Drug Synergism; Gefitinib; Humans; Lung Neoplasms; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Up-Regulation | 2017 |
Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation.
Topics: A549 Cells; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Synergism; ErbB Receptors; Female; Gene Expression Regulation, Enzymologic; Genes, ras; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; STAT3 Transcription Factor; Sulfonamides; Survivin; Xenograft Model Antitumor Assays | 2018 |
Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells.
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Autophagy; Cell Cycle; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; RNA, Small Interfering; Signal Transduction; Tumor Burden; Vacuoles; Xenograft Model Antitumor Assays | 2018 |
Hyaluronic acid - dihydroartemisinin conjugate: Synthesis, characterization and in vitro evaluation in lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Proliferation; Cell Survival; Chemistry Techniques, Synthetic; Humans; Hyaluronic Acid; Lung Neoplasms; Membrane Potential, Mitochondrial; Nanoparticles; Reactive Oxygen Species | 2019 |
Development of R
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Drug Liberation; Epirubicin; Humans; Lipid Bilayers; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2019 |
DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Time Factors; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells.
Topics: Absorbable Implants; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Survival; Coloring Agents; Drug Carriers; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gelatin; Humans; Hyaluronic Acid; Lung Neoplasms; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Tetrazolium Salts; Thiazoles | 2014 |
Dihydroartemisinine enhances dictamnine-induced apoptosis via a caspase dependent pathway in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Artemisinins; Caspase 3; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Quinolines; S Phase Cell Cycle Checkpoints; Signal Transduction | 2013 |
Targeted efficacy of dihydroartemisinin for translationally controlled protein expression in a lung cancer model.
Topics: Antimalarials; Apoptosis; Artemisinins; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; DNA, Neoplasm; Humans; Lung Neoplasms; Real-Time Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1 | 2014 |
Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Polyethylene Glycols; Solubility; Structure-Activity Relationship; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
[Effect of dihydroartemisinin combined irradiation on the apoptosis of human lung cancer GLC-82 cells and its mechanism study].
Topics: Apoptosis; Artemisinins; bcl-2-Associated X Protein; Cell Cycle; Cell Proliferation; Down-Regulation; Flow Cytometry; Humans; Lung Neoplasms; Neoplasm Proteins; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2014 |
Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction | 2014 |
Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
Topics: Adenosine Triphosphate; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Caspase 8; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Lung Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Topics: A549 Cells; Animals; Antimalarials; Artemisinins; Artesunate; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; RNA Interference; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
Topics: A549 Cells; Animals; Antimalarials; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Ribonucleases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.
Topics: Animals; Antimalarials; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Female; Glucose Transporter Type 1; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B | 2016 |
Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Artemisinins; Bronchi; Cell Cycle Checkpoints; Cell Survival; DNA Damage; Epithelial Cells; Humans; Lung Neoplasms; Oxides; Reactive Oxygen Species | 2017 |
Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells.
Topics: Amino Acid Chloromethyl Ketones; Antimalarials; Apoptosis; Artemisinins; Caspase 3; Cell Line, Tumor; Cell Shape; Cell Survival; Cysteine Proteinase Inhibitors; Enzyme Activation; Fluorescence Resonance Energy Transfer; Humans; Lung; Lung Neoplasms; Medicine, Chinese Traditional; Membrane Potential, Mitochondrial; Mitochondria | 2009 |
Dihydroarteminsin-induced apoptosis is not dependent on the translocation of Bim to the endoplasmic reticulum in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Apoptosis Regulatory Proteins; Artemisinins; Bcl-2-Like Protein 11; Cell Line, Tumor; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Flow Cytometry; Gene Knockdown Techniques; Humans; Immunohistochemistry; Lung Neoplasms; Membrane Proteins; Proto-Oncogene Proteins; RNA, Small Interfering | 2012 |
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.
Topics: Antimalarials; Apoptosis; Artemisinins; Blotting, Western; Calcium; Cell Line, Tumor; Chelating Agents; DNA Fragmentation; DNA, Neoplasm; Egtazic Acid; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; Humans; Imidazoles; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Sesquiterpenes; Tetrazolium Salts; Thiazoles | 2008 |